Keywords: biogen, psoriasis, drug, set, phase, iii, trials

Biogen psoriasis drug set for Phase III trials

Article | 02 June 1999

Print This

Biogen has reported encouraging data on its candidate drug forpsoriasis, Amevive (recombinant LFA-3/IgG1 human fusion protein) and says it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in